Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity

American Heart Journal

Volumn 150, Issue 5, 2005, Pages 1106.e1-1106.e6

  Harris, Kevin M ^a   Aeppli, Dorothee M ^b   Carey, Charles F ^c  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Metro Heart Group of St Louis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROHORMONE; RAMIPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ECHOCARDIOGRAPHY; ENZYME INHIBITION; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE SIZE; HORMONE BLOOD LEVEL; HUMAN; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 27744497408     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.07.023     Document Type: Article

References (22)

1. M. Enriquez-Sarano, A. Basmadjian, and A. Rossi Progression of mitral regurgitation J Am Coll Cardiol 34 1999 1137 1144
2. R.O. Bonow, B. Carabello, and A.C. de Leon Jr Guidelines for the Management of Patients With Valvular Heart Disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease) Circulation 98 1998 1949 1984
3. A.M. Kizilbash, D.L. Willett, and M.E. Brickner Effects of afterload reduction on vena contracta width in mitral regurgitation J Am Coll Cardiol 32 1998 427 431
4. H.J. Levine, and W.H. Gaasch Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves J Am Coll Cardiol 28 1996 1083 1091
5. T. Wisenbaugh, V. Sinovich, and A. Dullabh Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation J Heart Valve Dis 3 1994 197 204
6. H.R. Schon Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation J Hypertens Suppl 12 1994 S95 S104
7. U. Host, H. Kelbaek, and P. Hildebrandt Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse Am J Cardiol 80 1997 655 658
8. M.D. Tischler, M. Rowan, and M.M. LeWinter Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse Am J Cardiol 82 1998 242 245
9. F. Marcotte, G.N. Honos, and A.D. Walling Effect of angiotensin- converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function Can J Cardiol 13 1997 479 485
10. K.S. Dujardin, M. Enriquez-Sarano, and K.R. Bailey Effect of losartan on degree of mitral regurgitation quantified by echocardiography Am J Cardiol 87 2001 570 576
11. I. Heck, J. Schmidt, and H. Mattern Reduction of regurgitation in aortic and mitral insufficiency by captopril in acute and long-term trials Schweiz Med Wochenschr 115 1985 1615 1618
12. I.R. Rivera, V.A. Moises, and A.C. Carvalho Mildly symptomatic chronic mitral regurgitation. Analysis of left ventricular systolic function and mitral regurgitation fraction under pharmacological influence. Echocardiographic study Arq Bras Cardiol 80 2003 144 149
13. D.K. Gupta, A. Kapoor, and N. Garg Beneficial effects of nicorandil versus enalapril in chronic rheumatic severe mitral regurgitation: six months follow up echocardiographic study J Heart Valve Dis 10 2001 158 165
14. N.J. Brown, and D.E. Vaughan Angiotensin-converting enzyme inhibitors Circulation 97 1998 1411 1420
15. M. Enriquez-Sarano, F.A. Miller Jr, and S.N. Hayes Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method J Am Coll Cardiol 25 1995 703 709
16. W.A. Zoghbi, M. Enriquez-Sarano, and E. Foster Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802
17. D. Mele, P. Vandervoort, and I. Palacios Proximal jet size by Doppler color flow mapping predicts severity of mitral regurgitation Circulation 91 1995 746 754
18. P.M. Shah, M. Crawford, and A. DeMaria Recommendations for quantitation of the left ventricle by two-dimensional echocardiography J Am Soc Echocardiogr 2 1989 358 367
19. T.M. Sutton, R.A. Stewart, and I.L. Gerber Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation J Am Coll Cardiol 41 2003 2280 2287
20. T.S. Rector, and J.N. Cohn Assessment of patient outcome with the Minnesota Living With Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan multicenter research group Am Heart J 124 1992 1017 1025
21. J.S. Borer, and R.O. Bonow Contemporary approach to aortic and mitral regurgitation Circulation 108 2003 2432 2438
22. S. Nemoto, M. Hamawaki, and G. De Freitas Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation J Am Coll Cardiol 40 2002 149 154